ArticleNPJ Parkinson's disease2025

A brain-shuttled antibody targeting alpha synuclein aggregates for the treatment of synucleinopathies.

Sungwon An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.